Search

Search Results
Results 58691 - 58700 of 58730 for Cancer Research
  • CellSense Technologies
    Supplier - 8 Jul 2024
    CellSense Technologies is a manufacturer of advanced Brillouin Microscope systems for mechanobiological applications ranging from cell biology to biomedicine, from developmental biology to tissue...
  • Walter and Eliza Hall Institute of Medical Research (WEHI)
    Supplier - 20 Dec 2022
    WEHI (formerly the Walter and Eliza Hall Institute of Medical Research) brings the world’s brightest minds together to make life-changing discoveries. With more than 1000 researchers from across the...
  • Stoller Biomarker Discovery Centre
    Supplier - 30 Nov 2020
    The Stoller Biomarker Discovery Centre aims to identify biomarkers that could be used to diagnose or inform treatment of diseases such as cancer and arthritis.
  • Iksuda Therapeutics
    Supplier - 7 Jun 2021
    Iksuda Therapeutics is creating next-generation, class-leading ADCs
  • R&D Systems
    Supplier - 22 May 2019
    Supplier profile for R&D Systems on News-Medical.
  • Daylight Solutions Inc
    Supplier - 15 Apr 2015
    Daylight Solutions was founded in January, 2005 by three high tech entrepreneurs. Today the company consists of 60 people who share a vision of developing and advancing breakthrough technologies and...
  • Stilla Technologies
    Supplier - 20 Jun 2024
    Stilla Technologies is a multiplex digital PCR company that transforms complex genomic data into actionable insights across a wide range of research and clinical applications, including cancer and...
  • Scientifica
    Supplier - 21 Nov 2023
    Who Are We? We support researchers in achieving breakthroughs in neuroscience, cardiology, cancer, and various scientific fields by supplying cutting-edge electrophysiology, multiphoton imaging, and...
  • NK:IO Limited
    Supplier - 11 Jul 2023
    NK:IO reimagines cancer treatment. By harnessing the potential of the innate immune system, we are developing ground breaking NK cell and small molecule therapies targeting both haematological and...
  • Avacta Life Sciences Ltd.
    Supplier - 14 Nov 2019
    Our mission is to shape the future of medicine by developing safe and efficacious drugs, and powerful research and diagnostic tools, based on our proprietary Affimer® and pre|CISIONTM platforms.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback